CEL-SCI Corp. (CVM)
6.27
-0.18
(-2.79%)
USD |
NYAM |
Dec 08, 16:00
6.375
+0.10
(+1.67%)
After-Hours: 20:00
CEL-SCI Total Liabilities (Quarterly): 13.31M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.34M |
| Shareholders Equity (Quarterly) | 7.025M |
| Debt to Equity Ratio | 1.418 |
| Current Ratio | 0.467 |
| Net Debt Paydown Yield | 7.68% |